Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejca.2021.05.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Axitinib-related cardiac dysfunction occurring after resumption of treatment.
Eur J Cancer
August 2021
Department of Cardiovascular Medicine, Nishinomiya Municipal Central Hospital, Nishinomiya, Hyogo, Japan.
Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma.
J Oncol Pharm Pract
October 2020
Division of Medical Oncology, Department of Internal Medicine, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey.
Introduction: Tyrosine kinase inhibitors and immune checkpoint inhibitors are widely used in advanced renal cell carcinoma. Here we reported a left ventricular dysfunction associated with axitinib and nivolumab experience in this patient with heart failure.
Case Report: A 70-year-old male patient with advanced renal cell carcinoma was treated with interferon alpha-2b 10 million U thrice weekly.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!